Results from the first step of a phase II study of vaccination with autologous dendritic cells loaded with autologous tumour homogenate in glioblastoma.

被引：0
|
作者：
Ridolfi, Laura
Gurrieri, Lorena
Riva, Nada
Bulgarelli, Jenny
De Rosa, Francesco
Guidoboni, Massimo
Fausti, Valentina
Ranallo, Nicoletta
Tazzari, Marcella
Petrini, Massimiliano
Granato, Anna Maria
Pancisi, Elena
Foca, Flavia
Dall'Agata, Monia
Amadori, Elena
Cortesi, Pietro
Gamboni, Alessandro
Pasini, Giuseppe
Ibrahim, Toni
Tosatto, Luigino
机构：
[1] IRCCS Ist Romagnolo Studio Tumori Dino Amadori IR, Meldola, Italy
[2] IRCCS Ist Romagnolo Studio Tumori IRST Dino Amado, Immunotherapy Cell Therapy & Biobank Unit, Meldola, Italy
[3] AUSL Romagna, Dept Onclol & Hematol, Ravenna, Italy
[4] City Rimini Hosp, Dept Oncol, Rimini, Italy
[5] IRCCS Rizzoli Orthoped Inst, Bologna, Italy
[6] Maurizio Bufalini Hosp, Neurosurg Unit, Cesena, Cesena, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14025
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Vaccination with autologous dendritic cells loaded with autologous tumour homogenate in resected glioblastoma: A phase II study (CombiGVax)
    Ridolfi, L.
    Gurrieri, L.
    Riva, N.
    Fausti, V.
    Bongiovanni, A.
    Di Menna, G.
    De Rosa, F.
    Guidoboni, M.
    Mercatali, L.
    Bulgarelli, J.
    Foca, F.
    Tazzari, M.
    Calpona, S.
    Petrini, M.
    Granato, A.
    Pancisi, E.
    Dall'Agata, M.
    Valmorri, L.
    Tosatto, L.
    Ibrahim, T.
    ANNALS OF ONCOLOGY, 2021, 32 : S529 - S529
  • [2] Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised "proof-of-principle" phase II study
    de Rosa, Francesco
    Ridolfi, Laura
    Ridolfi, Ruggero
    Gentili, Giorgia
    Valmorri, Linda
    Nanni, Oriana
    Petrini, Massimiliano
    Fiammenghi, Laura
    Granato, Anna Maria
    Ancarani, Valentina
    Pancisi, Elena
    Soldati, Valentina
    Cassan, Serena
    Riccobon, Angela
    Parisi, Elisabetta
    Romeo, Antonino
    Turci, Livia
    Guidoboni, Massimo
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [3] Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised “proof-of-principle” phase II study
    Francesco de Rosa
    Laura Ridolfi
    Ruggero Ridolfi
    Giorgia Gentili
    Linda Valmorri
    Oriana Nanni
    Massimiliano Petrini
    Laura Fiammenghi
    Anna Maria Granato
    Valentina Ancarani
    Elena Pancisi
    Valentina Soldati
    Serena Cassan
    Angela Riccobon
    Elisabetta Parisi
    Antonino Romeo
    Livia Turci
    Massimo Guidoboni
    Journal of Translational Medicine, 12
  • [4] First results of a phase II study:: Vaccine therapy with autologous, tumour lysate-pulsed dendritic cells in patients with metastasised pancreatic cancer
    Bauer, C
    Dauer, M
    Schnurr, M
    Junkmann, J
    Kiefl, R
    Conrad, C
    Rüttinger, D
    Bruns, C
    Jauch, KW
    Endres, S
    Eigler, A
    MEDIZINISCHE KLINIK, 2006, 101 (04) : A41 - A41
  • [5] Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccination
    Francesco Pasqualetti
    Sofia Zanotti
    British Journal of Cancer, 2023, 129 : 895 - 896
  • [6] Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccination
    Pasqualetti, Francesco
    Zanotti, Sofia
    BRITISH JOURNAL OF CANCER, 2023, 129 (06) : 895 - 896
  • [7] Vaccination therapy of pancreatic carcinoma patients with autologous, tumor-lysate pulsed dendritic cells: Results of a phase II study
    Bauer, C.
    Dauer, M.
    Schnurr, M.
    Jauch, K.
    Ruettinger, D.
    Conrad, C.
    Bruns, C.
    Emmerich, B.
    Endres, S.
    Eigler, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Phase II trial of therapeutic vaccine consisting of autologous dendritic cells loaded with autologous tumor cell antigens from self-renewing cancer cells in patients with newly diagnosed glioblastoma
    Bota, Daniela
    Piccioni, David
    LaRocca, Renato
    Duma, Christopher
    Aiken, Robert
    Kesari, Santosh
    Carrillo, Jose
    Taylor, Thomas
    Hsieh, Candace
    Nistor, Gabriel
    Dillman, Robert
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [9] Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma: What happened to the evidence?
    Olivier, T.
    Migliorini, D.
    REVUE NEUROLOGIQUE, 2023, 179 (05) : 502 - 505
  • [10] First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)
    Ridolfi, Laura
    Gurrieri, Lorena
    Riva, Nada
    Bulgarelli, Jenny
    De Rosa, Francesco
    Guidoboni, Massimo
    Fausti, Valentina
    Ranallo, Nicoletta
    Calpona, Sebastiano
    Tazzari, Marcella
    Petrini, Massimiliano
    Granato, Anna Maria
    Pancisi, Elena
    Foca, Flavia
    D'Allagata, Monia
    Bondi, Isabella
    Amadori, Elena
    Cortesi, Pietro
    Zani, Chiara
    Ancarani, Valentina
    Gamboni, Alessandro
    Polselli, Antonio
    Pasini, Giuseppe
    Bartolini, Daniela
    Maimone, Giuseppe
    Arpa, Donatella
    Tosatto, Luigino
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345